CIK 0001477449
- Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043705970
- Phone
- +1 203-635-2002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-20 | GOREVIC JASON N Chief Executive Officer | Exercise or conversion · Employee Stock Option (right to buy) | −9,988 | 79,618 | ||
| 2018-12-20 | GOREVIC JASON N Chief Executive Officer | Exercise or conversion · Employee Stock Option (right to buy) | −33,276 | 122,243 | ||
| 2018-12-19 | GOREVIC JASON N Chief Executive Officer | Exercise or conversion | +30,000 | $1.07 | $32K | 536,184 |
| 2018-12-19 | GOREVIC JASON N Chief Executive Officer | Sale | −30,000 | $49.55 | $1.5M | 506,184 |
| 2018-12-19 | GOREVIC JASON N Chief Executive Officer | Exercise or conversion · Employee Stock Option (right to buy) | −30,000 | 90,026 | ||
| 2018-12-18 | Turitz Andrew SVP - Business Development | Exercise or conversion | +2,734 | $6.01 | $16K | 3,910 |
| 2018-12-18 | Turitz Andrew SVP - Business Development | Sale | −2,734 | $50.01 | $137K | 1,176 |
| 2018-12-18 | Turitz Andrew SVP - Business Development | Exercise or conversion · Employee Stock Option (right to buy) | −2,734 | 0 | ||
| 2018-12-17 | Levy Lewis Chief Medical Officer | Exercise or conversion | +640 | $35.45 | $23K | 640 |
| 2018-12-17 | Levy Lewis Chief Medical Officer | Sale | −640 | $50.00 | $32K | 0 |
| 2018-12-17 | Levy Lewis Chief Medical Officer | Exercise or conversion · Employee Stock Option (right to buy) | −640 | 40,467 | ||
| 2018-12-13 | HIRSCHHORN MARK Executive VP, COO and CFO | Exercise or conversion | +1,001 | $1.67 | $2K | 3,658 |
| 2018-12-13 | HIRSCHHORN MARK Executive VP, COO and CFO | Exercise or conversion | +684 | $6.01 | $4K | 4,342 |
| 2018-12-13 | HIRSCHHORN MARK Executive VP, COO and CFO | Exercise or conversion | +2,284 | $6.01 | $14K | 6,626 |
| 2018-12-13 | HIRSCHHORN MARK Executive VP, COO and CFO | Exercise or conversion | +3,081 | $12.21 | $38K | 9,707 |
| 2018-12-13 | HIRSCHHORN MARK Executive VP, COO and CFO | Exercise or conversion | +293 | $22.30 | $7K | 10,000 |
| 2018-12-13 | HIRSCHHORN MARK Executive VP, COO and CFO | Exercise or conversion · Employee Stock Option (right to buy) | −1,001 | 7,008 | ||
| 2018-12-13 | HIRSCHHORN MARK Executive VP, COO and CFO | Exercise or conversion · Employee Stock Option (right to buy) | −684 | 6,151 | ||
| 2018-12-13 | HIRSCHHORN MARK Executive VP, COO and CFO | Exercise or conversion · Employee Stock Option (right to buy) | −2,284 | 29,692 | ||
| 2018-12-13 | HIRSCHHORN MARK Executive VP, COO and CFO | Exercise or conversion · Employee Stock Option (right to buy) | −3,081 | 83,194 |
Page 124 of 134 · 2,672 trades